![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
University Hospitals of Cleveland |
Information provided by: | University Hospitals of Cleveland |
ClinicalTrials.gov Identifier: | NCT00580346 |
People who aspirate after neurologic insults such as stroke often develop fatal pneumonia. This study examins the effects of dynamic vocal cord closure on swallowing. Implants placed over the chest wall are connected to electrodes placed around the nerve that closes the vocal cords. The patient triggers closure by flipping the switch of a coil taped over the skin covering the internal stimulator. Vocal cord motion is verified by videotaping through an endoscope, and the status of swallowing is documented radiologically by a modified barium swallow.
Condition | Intervention | Phase |
Neurological Insults Producing Aspiration Pneumonia |
Device: Modified Vocare Stimulator, and Huntington perineural electrodes |
Phase I |
MedlinePlus related topics: | Pneumonia |
Study Type: | Interventional |
Study Design: | Prevention, Double Blind (Caregiver, Investigator), Active Control, Single Group Assignment, Safety/Efficacy Study |
Estimated Enrollment: | 3 |
Study Start Date: | August 2004 |
Estimated Study Completion Date: | March 2008 |
Primary Completion Date: | December 2007 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
2: Experimental |
Device: Modified Vocare Stimulator, and Huntington perineural electrodes
Placement of stimulator over anterior chest wall, and electrodes around recurrent laryngeal nerve, and tunneling leads between both
|
Ages Eligible for Study: | 18 Years to 85 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Michael Broniatowski, MD | 216 363 2556 | mbron@prodigy.net |
United States, Ohio | |||||
University Hospitals health System | Recruiting | ||||
Cleveland, Ohio, United States, 44106 | |||||
Contact: Michael Broniatowski, MD 216-363-2556 mbron@prodigy.net |
University Hospitals of Cleveland |
Responsible Party: | University Hospitals of Cleveland health System ( Michael Broniatowski, MD ) |
Study ID Numbers: | 01-01-02, NIH DC-006703-01, IDE G980179 |
First Received: | December 21, 2007 |
Last Updated: | December 21, 2007 |
ClinicalTrials.gov Identifier: | NCT00580346 |
Health Authority: | United States: Food and Drug Administration |
|
|
![]() |